We are in this together.
WHO WE ARE
Taking on cancer requires grit and dedication.
All of us at Mythic Therapeutics—leaders, employees, and advisers—are dedicated to applying our collective capabilities, experience, and creativity toward developing a new dimension of antibody-drug conjugates (ADC) to transform the lives of patients.
Our powerful FateControl™ technology dramatically increases the therapeutic potency of ADCs without increasing toxicity, resulting in smarter and safer medicines that can target an array of tumor targets.